MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 48 filers reported holding MILLENDO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $939,000 | -21.2% | 177,825 | 0.0% | 0.43% | -0.2% |
| Q4 2019 | $1,191,000 | -5.8% | 177,825 | 0.0% | 0.43% | -26.5% |
| Q3 2019 | $1,264,000 | -38.5% | 177,825 | 0.0% | 0.58% | -23.4% |
| Q2 2019 | $2,056,000 | +122.3% | 177,825 | +187.5% | 0.76% | +122.8% |
| Q1 2019 | $925,000 | – | 61,860 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $9,930,000 | 3.10% |
| NEA Management Company, LLC | 1,766,779 | $12,562,000 | 1.04% |
| Samsara BioCapital, LLC | 186,540 | $1,326,000 | 0.90% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $9,158,000 | 0.84% |
| Bpifrance SA | 1,078,670 | $7,669,000 | 0.83% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,264,000 | 0.58% |
| ADAMS STREET PARTNERS LLC | 367,935 | $2,616,000 | 0.52% |
| Prosight Management, LP | 52,051 | $370,000 | 0.20% |
| GMT CAPITAL CORP | 53,419 | $380,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 38,881 | $276,000 | 0.00% |